Details for New Drug Application (NDA): 213584
✉ Email this page to a colleague
NDA 213584 describes OXYMETAZOLINE HYDROCHLORIDE, which is a drug marketed by Sun Pharma Canada and is included in one NDA. Additional details are available on the OXYMETAZOLINE HYDROCHLORIDE profile page.
The generic ingredient in OXYMETAZOLINE HYDROCHLORIDE is oxymetazoline hydrochloride. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the oxymetazoline hydrochloride profile page.
The generic ingredient in OXYMETAZOLINE HYDROCHLORIDE is oxymetazoline hydrochloride. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the oxymetazoline hydrochloride profile page.
Summary for 213584
| Tradename: | OXYMETAZOLINE HYDROCHLORIDE |
| Applicant: | Sun Pharma Canada |
| Ingredient: | oxymetazoline hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 213584
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | 1% | ||||
| Approval Date: | Oct 4, 2021 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
